FDA classifies Abiomed Automated Impella Controller removal as Class I
Published November 8, 2026 · Coverage November 1–7, 2026, Pacific · Medium priority
FDA's weekly Enforcement Report dated November 4, 2026 lists three Class I recall entries (Z-0208-2027, Z-0209-2027, Z-0210-2027) for Abiomed Automated Impella Controller (AIC) products, classified October 28, 2026. Abiomed's review of servicing records found controllers needing hardware, firmware or software updates, with issues including failure to recognize the purge cassette, a sticking button and possible loss of console control, and start-up instability. FDA's recall page, updated after this edition's coverage week, says hospital inventory can continue to be used while awaiting service from Abiomed.
Background
The Automated Impella Controller is the primary user control interface for Impella catheter-based heart pumps; it controls the catheter and monitors it for alarms. FDA issued an Early Alert on this issue on September 23, 2026, after Abiomed's September 18, 2026 letter to affected customers.
Who this affects
Hospitals with cardiac catheterization, cardiac surgery or critical care programs using Impella heart pumps with Automated Impella Controller consoles.
Why it matters
FDA has identified this recall as the most serious type, and its recall page says that without the hardware, firmware or software updates patients could face problems such as delay of therapy, inadequate or loss of hemodynamic result, and other serious issues. Biomedical engineering should match console serial numbers to the affected list and track Abiomed service scheduling; clinical teams should know the issues while consoles remain in use. Inference: backup console availability during service windows may need planning.
Required actions
- None stated as a legal requirement.
Recommended action
- Check AIC serial numbers against the affected list
- Coordinate service with Abiomed and log completion
- Brief cath lab and ICU staff on the listed failure modes
Scope and timing
- Authority status
- Other (FDA Class I recall classification of a firm-initiated removal)
- Responsible owner
- Biomedical Engineering; Cardiovascular Services
- Publication date
- 2026-11-04 (FDA Enforcement Report date)
- Other dates
- Recall initiated 2026-09-18 (firm letter); center classification date 2026-10-28; FDA recall page update 2026-11-09 (after this edition's coverage week)
Not established
The FDA recall page was updated 2026-11-09, after this edition's coverage week; its timeline shows the Early Alert was issued 2026-09-23.
Sources
Complete edition and supplemental material
This article in the complete report →
Executive triage, source-coverage limitations, context and forward horizons remain in the complete report.
Read the entire Compliance Sweep report →